Feedback / Questions
reproxalap ophthalmic (ADX-102 ophthalmic) - Aldeyra
https://www.businesswire.com/news/home/20251215293677/en/Aldeyra-Therapeutics-Announces-PDUFA-Extension-of-the-New-Drug-Application-of-Reproxalap-for-the-Treatment-of-Dry-Eye-Disease
Dec 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next